TheProfitWatch

ARVN - Arvinas, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.95 0.5 (5.59%) --- --- --- -0.19 (-2.11%) 0.65 (7.39%) --- -0.19 (-2.11%)

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.84
Diluted EPS:
-0.84
Basic P/E:
-11.25
Diluted P/E:
-11.25
RSI(14) 1m:
25.81
VWAP:
9.46
RVol:
0.9902

Events

Period Kind Movement Occurred At
10m Price increase 10m 9.12 +0.32 (+3.64%) Oct 15 09:34
1m Price increase 1m 9.05 +0.24 (+2.78%) Oct 15 09:30
1m Price decrease 1m 8.76 -0.09 (-1.02%) Oct 15 08:14

Related News